SlideShare a Scribd company logo
MEDICAL
DEVICES
INTRODUCTION
A medical device can be any instrument,
apparatus, implement, machine, appliance,
implant, reagent for in vitro use, software,
material or other similar or related article,
intended by the manufacturer to be used,
alone or in combination for a medical purpose
REGULATION IN INDIA
In India medical devices are governed by
CDSCO(Central Drugs Standard Control Organization)
which is regulated by Directorate General of Health
Services , Ministry of Health and Family Welfare ,
Government of India.
CDSCO is the only government body which regulate the
medical devices.
Many committees had been set up and given their
opinion and recommendation , like the Mashelkar
Committee – Central Drug Standard Control
Organization.
 All these are now being taken into to form by the
Indian Medical Device regulatoryAct (IMRDA).
Indian Medical Devices RegulatoryAct came in
force on December 31,2009.
The composition of the committee is
represented by:
Central Governing Authority
Eminent Jurist
Two eminent medical practitioners
Two eminent medical technologists
Secretary General Quality council
IMRDA ESSENTIAL PRINCIPLES
Should not compromise health and safety
Design and manufacture of devices must conform
with safety principles
Long term safety should be ensured
Benefits of the devices must outweigh any side effects
Medical devices should be useful for the intended
purpose
IMRDA OBJECTIVES
Provide notification of essential principles
Provide for risk based classification of devices
Notify standards and guidelines
Provide mechanism of conformity
Provide a post market surveillance system
Provide for enforcement
IMRDA The regulation
Will issue
Design and manufacturing requirements
Performance evaluation
Demonstration of device standards , testing and
compliance
Regulation of post marketing follow up
Regulation of recalls
Legislate and punishment for non compliance
Principle of safety
IMRDA classification
ClassA– Devices involving low risk levels
Class B– devices involving low to medium risk
Class C – Devices involving moderate to high risk
Class D– Devices involving high risk.
The Drug and Cosmetic Act
Covers the pharmaceutical products and cosmetic.
Added medical devices as early as1992(syringes ,
needles, etc.)
As per the latest list of regulated medical devices , issued
on the 20/04/2010 , listed following devices:
Disposable hypodermic needles
Disposable hypodermic syringes
Disposable perfusion sets
In vitro diagnostic devices for HIV, HbsAg.
Cardiac stents
Catheters
Intra ocular lenses
Drug eluting stents
IV cannulae
Bone cement
Heart valve
Scalp vein sets
Orthopedic implant
Internal prosthetic replacement
The Drug and Cosmetic Act
Additionally following products are regulated as ‘Drugs’
under Drugs & CosmeticsAct & Rules there under:-
Blood grouping sera
Ligatures , sutures & staplers
Intra uterine devices
Condoms
Tubal rings
Surgical dressings
Blood/blood related products
SIGNIFICANCE OF MEDICAL DEVICES
The medical development in terms of drugs and
devices has brought about the robust change in the life
of the people.
Medical devices have extended the ability of
physicians to diagnose and treat diseases, making great
contributions to health and quality of life.
Like medicines and other health technologies, they are
essential for patient care at the bedside, at the rural
health clinics or at the large specialized hospitals.
ROLE OF PHARMACIST IN REGULATION
ON USE OF MEDICAL DEVICES
Pharmacist should:
 Have proper understanding of medical device
safety, risk involved, the degree of invasiveness,
duration of contact, the body system affected, and
local versus systemic effects.
 Be actively involved in the regulation of
effectiveness and performance of medical device.
LATEST DEVELOPMENT IN
MEDICAL DEVICE REGULATION
There are only14 medical devices regulated by Drug
Controller General of India (DCGI).
Currently, a number of specific medical devices are
regulated as drugs and fall under India’s Drugs and
CosmeticsAct (DCA).
Since 2008, both the Indian Department of Science and
Technology and the Ministry of Health have sought to
completely restructure the regulations for medical devices.
Department of Science and Technology : proposed creation
of a Medical Devices Regulatory Authority that would
operate similar to a division within the CDSCO.
Ministry of Health: proposed revision of the DCA that
would create a Central Drug Authority to function similarly
to the U.S. FDA.
The CDSCO is continuing to entrench its own medical
device regulation standards. In June 2009, it seemed as if
the CDSCO would begin its own form of medical device
regulations.
CDSCO: released schedule M-3 which provided an official
definition for medical devices, outlined a four level
medical device risk classification scheme, created a body
within the CDSCO to regulate medical devices in India.
 Ministry of Health and Family Welfare, Government of
India, with WHO funding, initiated a country wide
National Pharmacovigilance Program.
Medical Device Act.pptx

More Related Content

Similar to Medical Device Act.pptx

A Step-By-Step Guide To CDSCO _Medical Device Registration.pdf
A Step-By-Step Guide To CDSCO _Medical Device Registration.pdfA Step-By-Step Guide To CDSCO _Medical Device Registration.pdf
A Step-By-Step Guide To CDSCO _Medical Device Registration.pdf
PranshuCorpseed
 
CDSCO Regulatory Authority.pptx
CDSCO Regulatory Authority.pptxCDSCO Regulatory Authority.pptx
CDSCO Regulatory Authority.pptx
Prachi Pandey
 
CDSCO Regulatory Authority.pdf
CDSCO Regulatory Authority.pdfCDSCO Regulatory Authority.pdf
CDSCO Regulatory Authority.pdf
Prachi Pandey
 
CDSCO Regulatory Authority.pptx
CDSCO Regulatory Authority.pptxCDSCO Regulatory Authority.pptx
CDSCO Regulatory Authority.pptx
RAHUL PAL
 
EU regulatory frameworks - Legal challenges and opportunities for digital hea...
EU regulatory frameworks - Legal challenges and opportunities for digital hea...EU regulatory frameworks - Legal challenges and opportunities for digital hea...
EU regulatory frameworks - Legal challenges and opportunities for digital hea...
DayOne
 
Presentation: Therapeutic Goods Administration: An introduction to the work o...
Presentation: Therapeutic Goods Administration: An introduction to the work o...Presentation: Therapeutic Goods Administration: An introduction to the work o...
Presentation: Therapeutic Goods Administration: An introduction to the work o...
TGA Australia
 
Ghtf study group 4
Ghtf study group 4Ghtf study group 4
Ghtf study group 4
sangeethapriyas3
 
Medical Equipment 2023 4th YR(1).pdf
Medical Equipment 2023 4th YR(1).pdfMedical Equipment 2023 4th YR(1).pdf
Medical Equipment 2023 4th YR(1).pdf
AhmanurSule5
 
Today's Healthcare Technology and the Regulatory Standpoint
Today's Healthcare Technology and the Regulatory StandpointToday's Healthcare Technology and the Regulatory Standpoint
Today's Healthcare Technology and the Regulatory Standpoint
Akshay Anand
 
Layout of starting the medical device business in India.
Layout of starting the medical device business in India.Layout of starting the medical device business in India.
Layout of starting the medical device business in India.
Mayank Saini
 
Industry and fda laision &
Industry and fda laision &Industry and fda laision &
Industry and fda laision &
BhanuSriChandanaKnch
 
Presentation_Medical device registartion Malaysia.pdf
Presentation_Medical device registartion Malaysia.pdfPresentation_Medical device registartion Malaysia.pdf
Presentation_Medical device registartion Malaysia.pdf
andrijanakankaras1
 
IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...
IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...
IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...
ijcax
 
NEW DRUGS , COSMETICS , MEDICAL DEVICES BILL.pptx
NEW DRUGS , COSMETICS , MEDICAL DEVICES BILL.pptxNEW DRUGS , COSMETICS , MEDICAL DEVICES BILL.pptx
NEW DRUGS , COSMETICS , MEDICAL DEVICES BILL.pptx
SuvarnsingPardeshi
 
CLINICAL TRIALS OF MEDICAL DEVICES
CLINICAL TRIALS OF MEDICAL DEVICESCLINICAL TRIALS OF MEDICAL DEVICES
CLINICAL TRIALS OF MEDICAL DEVICES
Dwaipayan chakraborty
 
Medical Devices
Medical DevicesMedical Devices
Medical Devicespviral24
 
A New Regulatory Model for India
A New Regulatory Model for IndiaA New Regulatory Model for India
A New Regulatory Model for India
Heena Thakkar
 
Medical devices and IVD'S
Medical devices and IVD'SMedical devices and IVD'S
Medical devices and IVD'S
SanthiNori1
 
Decree 98/2021/NĐ-CP About medical equipment management
Decree 98/2021/NĐ-CP About medical equipment managementDecree 98/2021/NĐ-CP About medical equipment management
Decree 98/2021/NĐ-CP About medical equipment management
MedGate Vietnam| Regulatory Affairs of Pharmaceutical, Medical Devices, Cosmetic
 
overview of Japan pharmaceutical regulatory authority - PMDA
overview of Japan  pharmaceutical regulatory authority - PMDAoverview of Japan  pharmaceutical regulatory authority - PMDA
overview of Japan pharmaceutical regulatory authority - PMDA
Nandhanan
 

Similar to Medical Device Act.pptx (20)

A Step-By-Step Guide To CDSCO _Medical Device Registration.pdf
A Step-By-Step Guide To CDSCO _Medical Device Registration.pdfA Step-By-Step Guide To CDSCO _Medical Device Registration.pdf
A Step-By-Step Guide To CDSCO _Medical Device Registration.pdf
 
CDSCO Regulatory Authority.pptx
CDSCO Regulatory Authority.pptxCDSCO Regulatory Authority.pptx
CDSCO Regulatory Authority.pptx
 
CDSCO Regulatory Authority.pdf
CDSCO Regulatory Authority.pdfCDSCO Regulatory Authority.pdf
CDSCO Regulatory Authority.pdf
 
CDSCO Regulatory Authority.pptx
CDSCO Regulatory Authority.pptxCDSCO Regulatory Authority.pptx
CDSCO Regulatory Authority.pptx
 
EU regulatory frameworks - Legal challenges and opportunities for digital hea...
EU regulatory frameworks - Legal challenges and opportunities for digital hea...EU regulatory frameworks - Legal challenges and opportunities for digital hea...
EU regulatory frameworks - Legal challenges and opportunities for digital hea...
 
Presentation: Therapeutic Goods Administration: An introduction to the work o...
Presentation: Therapeutic Goods Administration: An introduction to the work o...Presentation: Therapeutic Goods Administration: An introduction to the work o...
Presentation: Therapeutic Goods Administration: An introduction to the work o...
 
Ghtf study group 4
Ghtf study group 4Ghtf study group 4
Ghtf study group 4
 
Medical Equipment 2023 4th YR(1).pdf
Medical Equipment 2023 4th YR(1).pdfMedical Equipment 2023 4th YR(1).pdf
Medical Equipment 2023 4th YR(1).pdf
 
Today's Healthcare Technology and the Regulatory Standpoint
Today's Healthcare Technology and the Regulatory StandpointToday's Healthcare Technology and the Regulatory Standpoint
Today's Healthcare Technology and the Regulatory Standpoint
 
Layout of starting the medical device business in India.
Layout of starting the medical device business in India.Layout of starting the medical device business in India.
Layout of starting the medical device business in India.
 
Industry and fda laision &
Industry and fda laision &Industry and fda laision &
Industry and fda laision &
 
Presentation_Medical device registartion Malaysia.pdf
Presentation_Medical device registartion Malaysia.pdfPresentation_Medical device registartion Malaysia.pdf
Presentation_Medical device registartion Malaysia.pdf
 
IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...
IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...
IMPACT OF APPLYING INTERNATIONAL QUALITY STANDARDS ON MEDICAL EQUIPMENT IN SA...
 
NEW DRUGS , COSMETICS , MEDICAL DEVICES BILL.pptx
NEW DRUGS , COSMETICS , MEDICAL DEVICES BILL.pptxNEW DRUGS , COSMETICS , MEDICAL DEVICES BILL.pptx
NEW DRUGS , COSMETICS , MEDICAL DEVICES BILL.pptx
 
CLINICAL TRIALS OF MEDICAL DEVICES
CLINICAL TRIALS OF MEDICAL DEVICESCLINICAL TRIALS OF MEDICAL DEVICES
CLINICAL TRIALS OF MEDICAL DEVICES
 
Medical Devices
Medical DevicesMedical Devices
Medical Devices
 
A New Regulatory Model for India
A New Regulatory Model for IndiaA New Regulatory Model for India
A New Regulatory Model for India
 
Medical devices and IVD'S
Medical devices and IVD'SMedical devices and IVD'S
Medical devices and IVD'S
 
Decree 98/2021/NĐ-CP About medical equipment management
Decree 98/2021/NĐ-CP About medical equipment managementDecree 98/2021/NĐ-CP About medical equipment management
Decree 98/2021/NĐ-CP About medical equipment management
 
overview of Japan pharmaceutical regulatory authority - PMDA
overview of Japan  pharmaceutical regulatory authority - PMDAoverview of Japan  pharmaceutical regulatory authority - PMDA
overview of Japan pharmaceutical regulatory authority - PMDA
 

More from MonishaReddy31

Drugs used to Congestive Heart Failure- Cardiac glycosides
Drugs used to Congestive Heart Failure- Cardiac glycosidesDrugs used to Congestive Heart Failure- Cardiac glycosides
Drugs used to Congestive Heart Failure- Cardiac glycosides
MonishaReddy31
 
Inventory control: CHARGE FLOOR STOCK- Inventory methods
Inventory control: CHARGE FLOOR STOCK- Inventory methodsInventory control: CHARGE FLOOR STOCK- Inventory methods
Inventory control: CHARGE FLOOR STOCK- Inventory methods
MonishaReddy31
 
APPLICATION OF COMPUTER IN HOPITAL PHARMACY.pptx
APPLICATION OF COMPUTER IN HOPITAL PHARMACY.pptxAPPLICATION OF COMPUTER IN HOPITAL PHARMACY.pptx
APPLICATION OF COMPUTER IN HOPITAL PHARMACY.pptx
MonishaReddy31
 
FOOD WEB.pptx
FOOD WEB.pptxFOOD WEB.pptx
FOOD WEB.pptx
MonishaReddy31
 
NDCT.pptx
NDCT.pptxNDCT.pptx
NDCT.pptx
MonishaReddy31
 
ANDA , NDA.pptx
ANDA , NDA.pptxANDA , NDA.pptx
ANDA , NDA.pptx
MonishaReddy31
 
Disaster management act.pptx
Disaster management act.pptxDisaster management act.pptx
Disaster management act.pptx
MonishaReddy31
 
code o f pharmaceuticalethics.pptx
code o f pharmaceuticalethics.pptxcode o f pharmaceuticalethics.pptx
code o f pharmaceuticalethics.pptx
MonishaReddy31
 
Medical Device Act.pptx
Medical Device Act.pptxMedical Device Act.pptx
Medical Device Act.pptx
MonishaReddy31
 
GOOD REGULATORY PRACTICE.pptx
GOOD REGULATORY PRACTICE.pptxGOOD REGULATORY PRACTICE.pptx
GOOD REGULATORY PRACTICE.pptx
MonishaReddy31
 
ROLE OF INDIVIDUAL IN CONSERVATION NATURAL RESOURCES.pptx
ROLE OF INDIVIDUAL IN CONSERVATION NATURAL RESOURCES.pptxROLE OF INDIVIDUAL IN CONSERVATION NATURAL RESOURCES.pptx
ROLE OF INDIVIDUAL IN CONSERVATION NATURAL RESOURCES.pptx
MonishaReddy31
 
Screening Models for Diuretics Agents.pptx
Screening Models for Diuretics Agents.pptxScreening Models for Diuretics Agents.pptx
Screening Models for Diuretics Agents.pptx
MonishaReddy31
 
code o f pharmaceuticalethics.pptx
code o f pharmaceuticalethics.pptxcode o f pharmaceuticalethics.pptx
code o f pharmaceuticalethics.pptx
MonishaReddy31
 
CONSUMER PROTECTION ACT.pptx
CONSUMER PROTECTION ACT.pptxCONSUMER PROTECTION ACT.pptx
CONSUMER PROTECTION ACT.pptx
MonishaReddy31
 
GOOD REGULATORY PRACTICE.pptx
GOOD REGULATORY PRACTICE.pptxGOOD REGULATORY PRACTICE.pptx
GOOD REGULATORY PRACTICE.pptx
MonishaReddy31
 

More from MonishaReddy31 (15)

Drugs used to Congestive Heart Failure- Cardiac glycosides
Drugs used to Congestive Heart Failure- Cardiac glycosidesDrugs used to Congestive Heart Failure- Cardiac glycosides
Drugs used to Congestive Heart Failure- Cardiac glycosides
 
Inventory control: CHARGE FLOOR STOCK- Inventory methods
Inventory control: CHARGE FLOOR STOCK- Inventory methodsInventory control: CHARGE FLOOR STOCK- Inventory methods
Inventory control: CHARGE FLOOR STOCK- Inventory methods
 
APPLICATION OF COMPUTER IN HOPITAL PHARMACY.pptx
APPLICATION OF COMPUTER IN HOPITAL PHARMACY.pptxAPPLICATION OF COMPUTER IN HOPITAL PHARMACY.pptx
APPLICATION OF COMPUTER IN HOPITAL PHARMACY.pptx
 
FOOD WEB.pptx
FOOD WEB.pptxFOOD WEB.pptx
FOOD WEB.pptx
 
NDCT.pptx
NDCT.pptxNDCT.pptx
NDCT.pptx
 
ANDA , NDA.pptx
ANDA , NDA.pptxANDA , NDA.pptx
ANDA , NDA.pptx
 
Disaster management act.pptx
Disaster management act.pptxDisaster management act.pptx
Disaster management act.pptx
 
code o f pharmaceuticalethics.pptx
code o f pharmaceuticalethics.pptxcode o f pharmaceuticalethics.pptx
code o f pharmaceuticalethics.pptx
 
Medical Device Act.pptx
Medical Device Act.pptxMedical Device Act.pptx
Medical Device Act.pptx
 
GOOD REGULATORY PRACTICE.pptx
GOOD REGULATORY PRACTICE.pptxGOOD REGULATORY PRACTICE.pptx
GOOD REGULATORY PRACTICE.pptx
 
ROLE OF INDIVIDUAL IN CONSERVATION NATURAL RESOURCES.pptx
ROLE OF INDIVIDUAL IN CONSERVATION NATURAL RESOURCES.pptxROLE OF INDIVIDUAL IN CONSERVATION NATURAL RESOURCES.pptx
ROLE OF INDIVIDUAL IN CONSERVATION NATURAL RESOURCES.pptx
 
Screening Models for Diuretics Agents.pptx
Screening Models for Diuretics Agents.pptxScreening Models for Diuretics Agents.pptx
Screening Models for Diuretics Agents.pptx
 
code o f pharmaceuticalethics.pptx
code o f pharmaceuticalethics.pptxcode o f pharmaceuticalethics.pptx
code o f pharmaceuticalethics.pptx
 
CONSUMER PROTECTION ACT.pptx
CONSUMER PROTECTION ACT.pptxCONSUMER PROTECTION ACT.pptx
CONSUMER PROTECTION ACT.pptx
 
GOOD REGULATORY PRACTICE.pptx
GOOD REGULATORY PRACTICE.pptxGOOD REGULATORY PRACTICE.pptx
GOOD REGULATORY PRACTICE.pptx
 

Recently uploaded

Assignment_4_ArianaBusciglio Marvel(1).docx
Assignment_4_ArianaBusciglio Marvel(1).docxAssignment_4_ArianaBusciglio Marvel(1).docx
Assignment_4_ArianaBusciglio Marvel(1).docx
ArianaBusciglio
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
Priyankaranawat4
 
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
IreneSebastianRueco1
 
Reflective and Evaluative Practice PowerPoint
Reflective and Evaluative Practice PowerPointReflective and Evaluative Practice PowerPoint
Reflective and Evaluative Practice PowerPoint
amberjdewit93
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
chanes7
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
ArianaBusciglio
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
deeptiverma2406
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
thanhdowork
 
Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
Krisztián Száraz
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
Celine George
 
MERN Stack Developer Roadmap By ScholarHat PDF
MERN Stack Developer Roadmap By ScholarHat PDFMERN Stack Developer Roadmap By ScholarHat PDF
MERN Stack Developer Roadmap By ScholarHat PDF
scholarhattraining
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
taiba qazi
 
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Ashish Kohli
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
National Information Standards Organization (NISO)
 

Recently uploaded (20)

Assignment_4_ArianaBusciglio Marvel(1).docx
Assignment_4_ArianaBusciglio Marvel(1).docxAssignment_4_ArianaBusciglio Marvel(1).docx
Assignment_4_ArianaBusciglio Marvel(1).docx
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
 
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
RPMS TEMPLATE FOR SCHOOL YEAR 2023-2024 FOR TEACHER 1 TO TEACHER 3
 
Reflective and Evaluative Practice PowerPoint
Reflective and Evaluative Practice PowerPointReflective and Evaluative Practice PowerPoint
Reflective and Evaluative Practice PowerPoint
 
Digital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments UnitDigital Artifact 1 - 10VCD Environments Unit
Digital Artifact 1 - 10VCD Environments Unit
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Best Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDABest Digital Marketing Institute In NOIDA
Best Digital Marketing Institute In NOIDA
 
A Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptxA Survey of Techniques for Maximizing LLM Performance.pptx
A Survey of Techniques for Maximizing LLM Performance.pptx
 
Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
 
MERN Stack Developer Roadmap By ScholarHat PDF
MERN Stack Developer Roadmap By ScholarHat PDFMERN Stack Developer Roadmap By ScholarHat PDF
MERN Stack Developer Roadmap By ScholarHat PDF
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
 
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
Aficamten in HCM (SEQUOIA HCM TRIAL 2024)
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
 

Medical Device Act.pptx

  • 2. INTRODUCTION A medical device can be any instrument, apparatus, implement, machine, appliance, implant, reagent for in vitro use, software, material or other similar or related article, intended by the manufacturer to be used, alone or in combination for a medical purpose
  • 3.
  • 4. REGULATION IN INDIA In India medical devices are governed by CDSCO(Central Drugs Standard Control Organization) which is regulated by Directorate General of Health Services , Ministry of Health and Family Welfare , Government of India. CDSCO is the only government body which regulate the medical devices.
  • 5. Many committees had been set up and given their opinion and recommendation , like the Mashelkar Committee – Central Drug Standard Control Organization.  All these are now being taken into to form by the Indian Medical Device regulatoryAct (IMRDA). Indian Medical Devices RegulatoryAct came in force on December 31,2009.
  • 6. The composition of the committee is represented by: Central Governing Authority Eminent Jurist Two eminent medical practitioners Two eminent medical technologists Secretary General Quality council
  • 7. IMRDA ESSENTIAL PRINCIPLES Should not compromise health and safety Design and manufacture of devices must conform with safety principles Long term safety should be ensured Benefits of the devices must outweigh any side effects Medical devices should be useful for the intended purpose
  • 8. IMRDA OBJECTIVES Provide notification of essential principles Provide for risk based classification of devices Notify standards and guidelines Provide mechanism of conformity Provide a post market surveillance system Provide for enforcement
  • 9. IMRDA The regulation Will issue Design and manufacturing requirements Performance evaluation Demonstration of device standards , testing and compliance Regulation of post marketing follow up Regulation of recalls Legislate and punishment for non compliance Principle of safety
  • 10. IMRDA classification ClassA– Devices involving low risk levels Class B– devices involving low to medium risk Class C – Devices involving moderate to high risk Class D– Devices involving high risk.
  • 11.
  • 12.
  • 13. The Drug and Cosmetic Act Covers the pharmaceutical products and cosmetic. Added medical devices as early as1992(syringes , needles, etc.) As per the latest list of regulated medical devices , issued on the 20/04/2010 , listed following devices: Disposable hypodermic needles Disposable hypodermic syringes Disposable perfusion sets In vitro diagnostic devices for HIV, HbsAg. Cardiac stents
  • 14. Catheters Intra ocular lenses Drug eluting stents IV cannulae Bone cement Heart valve Scalp vein sets Orthopedic implant Internal prosthetic replacement
  • 15. The Drug and Cosmetic Act Additionally following products are regulated as ‘Drugs’ under Drugs & CosmeticsAct & Rules there under:- Blood grouping sera Ligatures , sutures & staplers Intra uterine devices Condoms Tubal rings Surgical dressings Blood/blood related products
  • 16. SIGNIFICANCE OF MEDICAL DEVICES The medical development in terms of drugs and devices has brought about the robust change in the life of the people. Medical devices have extended the ability of physicians to diagnose and treat diseases, making great contributions to health and quality of life. Like medicines and other health technologies, they are essential for patient care at the bedside, at the rural health clinics or at the large specialized hospitals.
  • 17. ROLE OF PHARMACIST IN REGULATION ON USE OF MEDICAL DEVICES Pharmacist should:  Have proper understanding of medical device safety, risk involved, the degree of invasiveness, duration of contact, the body system affected, and local versus systemic effects.  Be actively involved in the regulation of effectiveness and performance of medical device.
  • 18. LATEST DEVELOPMENT IN MEDICAL DEVICE REGULATION There are only14 medical devices regulated by Drug Controller General of India (DCGI). Currently, a number of specific medical devices are regulated as drugs and fall under India’s Drugs and CosmeticsAct (DCA). Since 2008, both the Indian Department of Science and Technology and the Ministry of Health have sought to completely restructure the regulations for medical devices.
  • 19. Department of Science and Technology : proposed creation of a Medical Devices Regulatory Authority that would operate similar to a division within the CDSCO. Ministry of Health: proposed revision of the DCA that would create a Central Drug Authority to function similarly to the U.S. FDA. The CDSCO is continuing to entrench its own medical device regulation standards. In June 2009, it seemed as if the CDSCO would begin its own form of medical device regulations.
  • 20. CDSCO: released schedule M-3 which provided an official definition for medical devices, outlined a four level medical device risk classification scheme, created a body within the CDSCO to regulate medical devices in India.  Ministry of Health and Family Welfare, Government of India, with WHO funding, initiated a country wide National Pharmacovigilance Program.